Top Markets
Coin of the day
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNS
Classifica tra le azioni #36527
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in... Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
Prezzo delle azioni
$5.34
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$2.59M
Variazione (1 giorno)
-11.00%
Variazione (1 anno)
313.95%
Paese
US
Scambia Jupiter Neurosciences, Inc. (JUNS)

Categoria

Cronologia dei frazionamenti azionari per Jupiter Neurosciences, Inc. (JUNS)
L’azione Jupiter Neurosciences, Inc. (simbolo: JUNS) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 15, 2026.
Una quota di JUNS acquistata prima di Aug 15, 2026 equivale oggi a 0 quote di JUNS.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE